Ching t et al. bmc cancer. 2020 20:612
WebOct 28, 2024 · Ching T, Duncan ME, Newman-Eerkes T, et al: Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute … WebApr 6, 2011 · Amna Tariq et al. Research article 07 May 2024 Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK Christopher I. Jarvis et al. Research article 06 May 2024 A single-center, retrospective study of COVID-19 features in children: a descriptive investigation Huijing Ma et al.
Ching t et al. bmc cancer. 2020 20:612
Did you know?
WebNov 10, 2024 · Background: For patients with multiple myeloma (MM), each additional line of therapy (LOT) is associated with lower response rates, shorter treatment duration and …
WebMar 18, 2015 · Background Epigenetic alterations are known to correlate with changes in gene expression among various diseases including cancers. However, quantitative … WebSep 1, 2024 · Background: Current standard practice for locally advanced rectal cancer (LARC) entails a multidisciplinary approach that includes preoperative chemoradiotherapy, followed by total mesorectal excision, and then adjuvant chemotherapy. The latter has been accompanied by low compliance rates and no survival benefit in phase III randomized …
WebJun 30, 2024 · Background: The clonoSEQ® Assay (Adaptive Biotechnologies Corporation, Seattle, USA) identifies and tracks unique disease-associated immunoglobulin (Ig) … WebFowler et al. BMC Cancer (2024) 20:2 Page 2 of 15. age and sex to account for the older age demographic of cancer patient populations. Weights for this adjustment were …
WebApr 20, 2024 · Immune checkpoint inhibitors (ICIs) targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) or programmed cell death-1 (PD-1) pathways are reshaping the landscape of cancer therapy, yielding unprecedented clinical success in treating multiple cancer types [].By blocking the inhibitory pathway between T lymphocytes and tumor cells or antigen …
WebMay 28, 2024 · Background The five-tiered Cambridge Prognostic Group (CPG) classification is a better predictor of prostate cancer-specific mortality than the traditional three-tiered classification (low, intermediate, and high risk). We investigated radical treatment rates according to CPG in men diagnosed with non-metastatic prostate … ion-8650WebApr 10, 2024 · The original article was published in Molecular Cancer 2024 19:99 View Full Text ... 30.612 - 5-year Impact Factor (2024) 5.195 - Source Normalized Impact per Paper ... Follow BMC. BMC Twitter page; BMC Facebook page; ion8 dishwasher safeWebDec 9, 2024 · Data are scarce regarding intravesical maintenance therapy (MT) with the low-dose bacillus Calmette–Guérin (BCG) Tokyo strain. We investigated the efficacy and … ion 8650 meter manualWebAug 24, 2024 · Methods: Post-mastectomy patients with T1-2N1 breast cancer were restaged according to the American Joint Committee on Cancer Staging Manual, 8th … ontario disability parking application formWebDec 3, 2024 · They should be implemented prospectively in ICI based clinical trials to develop reliable algorithms for palliative NSCLC treatment. Clinically relevant prognostic … ontario disability payment amountsWebThe current gold standards for the diagnosis of BC are invasive or lack the sensitivity to correctly identify the disease. Kamala Vanarsa, Jessica Castillo, Long Wang, Kyung Hyun Lee, Claudia Pedroza, Yair Lotan and Chandra Mohan. BMC Medicine 2024 21 :133. Research article Published on: 5 April 2024. Full Text. ion8 drink bottle tour 750ml - rose quartzWebDec 16, 2024 · An assessment of the potential miscalibration of cardiovascular disease risk predictions caused by a secular trend in cardiovascular disease in England. Alexander Pate. Tjeerd van Staa. Richard Emsley. Research article. Open Access. Published: 30 November 2024. Article: 289. This is part of 1 collection. ion8 750ml